DI NISIO, Marcello
 Distribuzione geografica
Continente #
NA - Nord America 7.843
AS - Asia 5.356
EU - Europa 4.372
SA - Sud America 799
AF - Africa 99
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 12
Totale 18.493
Nazione #
US - Stati Uniti d'America 7.694
SG - Singapore 2.456
CN - Cina 1.330
IE - Irlanda 775
RU - Federazione Russa 675
BR - Brasile 660
UA - Ucraina 622
VN - Vietnam 543
SE - Svezia 534
IT - Italia 483
TR - Turchia 428
GB - Regno Unito 362
DE - Germania 300
FR - Francia 205
FI - Finlandia 178
IN - India 143
HK - Hong Kong 113
CA - Canada 69
AR - Argentina 63
BD - Bangladesh 59
MX - Messico 55
AT - Austria 46
ES - Italia 39
JP - Giappone 37
NL - Olanda 37
PL - Polonia 36
IQ - Iraq 34
ZA - Sudafrica 31
BE - Belgio 25
ID - Indonesia 25
EC - Ecuador 23
TW - Taiwan 23
PK - Pakistan 19
CO - Colombia 14
CZ - Repubblica Ceca 14
KR - Corea 14
MA - Marocco 13
EU - Europa 12
PH - Filippine 12
SA - Arabia Saudita 12
UZ - Uzbekistan 12
AU - Australia 11
IL - Israele 11
JO - Giordania 11
KE - Kenya 11
EG - Egitto 10
PY - Paraguay 9
TN - Tunisia 9
VE - Venezuela 9
LT - Lituania 8
AZ - Azerbaigian 7
IR - Iran 7
TH - Thailandia 7
AE - Emirati Arabi Uniti 6
JM - Giamaica 6
MY - Malesia 6
RO - Romania 6
CL - Cile 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
LB - Libano 5
PE - Perù 5
QA - Qatar 5
UY - Uruguay 5
DZ - Algeria 4
KG - Kirghizistan 4
OM - Oman 4
PS - Palestinian Territory 4
AL - Albania 3
BH - Bahrain 3
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
EE - Estonia 3
GA - Gabon 3
HR - Croazia 3
KZ - Kazakistan 3
NO - Norvegia 3
SR - Suriname 3
BG - Bulgaria 2
BN - Brunei Darussalam 2
CH - Svizzera 2
CI - Costa d'Avorio 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
KW - Kuwait 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
SN - Senegal 2
TL - Timor Orientale 2
AM - Armenia 1
AO - Angola 1
DM - Dominica 1
GE - Georgia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
Totale 18.478
Città #
Singapore 1.763
Chandler 1.002
Jacksonville 865
San Jose 812
Dublin 763
Ashburn 577
Princeton 393
Dallas 372
Beijing 310
Izmir 271
Nanjing 216
Ho Chi Minh City 196
Los Angeles 196
Santa Clara 185
Altamura 184
Southend 177
Wilmington 169
Cambridge 137
Dearborn 132
The Dalles 118
Hanoi 107
Hong Kong 105
Boardman 90
Ann Arbor 83
Buffalo 79
Houston 78
Tongling 76
São Paulo 74
New York 73
Nanchang 71
Woodbridge 68
Helsinki 62
Chieti 61
Redondo Beach 61
Moscow 53
Munich 50
Kunming 47
Hebei 46
Orem 39
Seattle 38
Shenyang 36
Tianjin 36
Washington 36
Jiaxing 34
Tokyo 34
Warsaw 33
Dong Ket 31
Vienna 29
Nuremberg 28
Hefei 27
Council Bluffs 26
Haiphong 26
Pescara 26
Changsha 25
Montreal 25
Chennai 24
Poplar 24
Brussels 23
Chicago 23
Denver 23
Frankfurt am Main 22
London 22
Norwalk 22
Atlanta 21
Phoenix 20
Baghdad 19
Brooklyn 19
Da Nang 19
Johannesburg 19
Guangzhou 18
Rio de Janeiro 18
San Francisco 18
Amsterdam 17
Boston 17
Hangzhou 17
Manchester 17
Mexico City 16
Stockholm 16
Fairfield 14
Milan 14
Pune 14
Biên Hòa 13
Falls Church 13
Leawood 13
Mumbai 13
Rome 13
Shanghai 13
Ankara 12
Brasília 12
Dhaka 12
Taipei 12
Turku 12
Amman 11
Grevenbroich 11
Guayaquil 11
Olomouc 11
Porto Alegre 11
Toronto 11
Belo Horizonte 10
Buenos Aires 10
Totale 11.371
Nome #
Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study 240
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 165
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 162
Supportive management strategies for disseminated intravascular coagulation: An international consensus 160
24 weeks of Pilates-aerobic and educative training to improve body fat mass in elderly Serbian women 159
Circulating leptin is associated with oxidized LDL in postmenopausal women. 137
Treatment of Lower Extremity Superficial Thrombophlebitis 133
Soluble thrombomodulin and vascular adhesion molecule-1 are associated to leptin plasma levels in obese patients. 130
Microsatellite polymorphism of the human leptin gene (LEP) and risk of cardiovascular disease 127
Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis 126
A Proposal of the Modification of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Sepsis-Associated DIC 126
Effects of multiple inherited and acquired thrombophilia on outcomes of in-vitro fertilization 126
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 126
Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review 125
Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin: a new potential chemosensitizer for cancer therapy. 124
Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients. 122
Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity 122
Low-Dose Subcutaneous Tocilizumab to Prevent Disease Progression in Patients with Moderate COVID-19 Pneumonia and Hyperinflammation 121
Acute complications and mortality in hospitalized patients with coronavirus disease 2019: A systematic review and meta-analysis 120
Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 119
ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer 119
Non-O blood group and outcomes of in vitro fertilization 119
Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation 118
Dementia in patients with atrial fibrillation and the value of the Hachinski ischemic score 117
Anticoagulant treatment of cancer patients with pulmonary embolism in the real world: Actual use of low-molecular-weight heparin in cancer 117
Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness 117
Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis 117
Identification of three genetic risk factors for venous thrombosis using a multiplex allele-specific PCR assay: comparison of conventional and new alternative methods for the preparation of DNA from clinical samples 116
Whole-Arm ultrasound for suspected upper-extremity deep venous thrombosis in outpatients 114
Computerised cognitive training for preventing dementia in people with mild cognitive impairment 114
Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19 114
Low-molecular-weight heparin for the treatment of acute venous thromboembolism in patients with active cancer 113
Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis 113
Residual vein obstruction in patients diagnosed with acute isolated distal deep vein thrombosis associated with active cancer 112
Association of Factor VII Levels With Inflammatory Parameters in Hypercholesterolemic Patients. 111
Rivaroxaban for cancer-associated cardiac thrombosis 111
Effects of body composition on the procoagulant imbalance in obese patients 111
Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy 110
Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study 110
A clinical decision rule and D-dimer testing to rule out upper extremity deep vein thrombosis in high-risk patients 107
Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia 107
Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis 107
Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH 106
Improving the diagnostic management of upper extremity deep vein thrombosis 106
Edoxaban for treatment of venous thromboembolism in patients with cancer: Rationale and design of the hokusai VTE-cancer study 106
Safety and efficacy of low-dose fondaparinux (1.5mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: The FONDAIR study 106
Long-term clinical outcomes of splanchnic vein thrombosis results of an international registry 106
The hematocrit and platelet target in polycytemia vera 105
Increased phosphatidylserine exposure on platelets from hospitalized patients with acute medical illnesses 105
Antithrombotic therapy and cancer 105
Deep vein thrombosis and pulmonary embolism 104
Treatment of venous thromboembolism with rivaroxaban in relation to body weight: A sub-analysis of the EINSTEIN DVT/PE studies 104
Edoxaban for the treatment of cancer-associated venous thromboembolism 104
Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation 104
Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis 103
Use of heparins in patients with cancer: Individual participant data metaanalysis of randomised trials study protocol 103
Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation 103
Trasforming growth factor-beta 1 levels in hypertensive patients: association with body mass index and leptin. 102
Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 102
A worldwide survey to assess the current approach to the treatment of patients with cancer and venous thromboembolism 102
Management of venous thromboembolism in cancer patients: Considerations about the clinical practice guideline update of the American society of clinical oncology 102
Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta-analysis 102
Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis 102
Direct oral anticoagulant plasma levels in hospitalized COVID-19 patients treated with dexamethasone 101
Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife 100
Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy: A systematic review and meta-analysis 100
Cannabinoids for medical use: A systematic review and meta-analysis 99
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts 99
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer 99
Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study 98
Frailty phenotype as a predictor of bleeding and mortality in ambulatory patients receiving direct oral anticoagulants 97
Treatment for superficial infusion thrombophlebitis of the upper extremity. 97
The diagnostic management of upper extremity deep vein thrombosis: A review of the literature 97
Antithrombotic therapy for venous thromboembolism in patients with cancer: expert guidance 97
Transforming growth factor-β1 levels in hypertensive patients: association with body mass index and leptin 97
Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis 96
Cancer-associated unsuspected pulmonary embolism 96
Treatment with tirofiban for acute coronary syndrome (ACS): a systematic review and network analysis 95
Incidental pulmonary embolism in cancer patients: Interobserver agreement on the diagnosis and extent with a focus on distal clots 95
Splanchnic vein thrombosis: Current perspectives 95
D-Dimer test in cancer patients with suspected acute pulmonary embolism 95
Long-term performance of risk scores for venous thromboembolism in ambulatory cancer patients 95
Obesity, Poor Muscle Strength and the Risk of Venous Thromboembolism in Older Persons: the InCHIANTI Study 94
Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists 94
Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life 94
High-dose versus low-dose venous thromboprophylaxis in hospitalized patients with COVID-19: a systematic review and meta-analysis 93
Prevention of catheter-related venous thrombosis with nadroparin in patients receiving high dose chemotherapy for hematological malignancies, a randomized placebo controlled study 93
Clinical course of isolated distal deep vein thrombosis in patients with active cancer: A multicenter cohort study 93
D-Dimer Test In Cancer Patients With Suspected Acute Pulmonary Embolism 93
Extended venous thromboprophylaxis in patients hospitalized for acute ischemic stroke: A systematic review and meta-analysis 93
Decision analysis for cancer screening in idiopathic venous thromboembolism 92
Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome 92
Recanalization rate in patients with proximal vein thrombosis treated with the direct oral anticoagulants 91
Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study 91
PO-06 Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 91
Inhaled analgesia for pain management in labour 91
Superior vena cava syndrome from an intracardiac non-Hodgkin lymphoma. 90
Combined use of clinical pretest probability and D-dimer test in cancer patients with clinically suspected deep venous thrombosis 90
Computerised cognitive training for maintaining cognitive function in cognitively healthy people in late life 90
Anticoagulant treatment for upper extremity deep vein thrombosis: A systematic review and meta-analysis 90
Totale 10.949
Categoria #
all - tutte 80.209
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.209


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021197 0 0 0 0 0 0 0 0 0 68 50 79
2021/2022758 10 10 9 116 35 27 31 65 53 22 107 273
2022/20232.957 249 388 133 308 328 586 156 227 384 43 95 60
2023/20241.286 98 45 141 48 106 373 254 49 27 39 5 101
2024/20252.995 200 619 402 63 52 98 76 250 345 130 353 407
2025/20266.489 506 273 772 855 718 403 1.128 484 813 537 0 0
Totale 19.223